In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CHL leads Vascular Pathways' $14mm Series B

Executive Summary

CHL Medical Partners has led Vascular Pathways Inc.'s (catheters for easy insertion of intravenous therapeutics) $14mm Series B venture round. Ascension Health Ventures, MVM Life Science Partners, and Arcus Ventures also participated. Representatives from CHL, MVM, and Ascension will take seats on the company's board.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies